#obesity

The risk for cardiovascular events and all-cause mortality were greatly reduced in people with obesity and fatty liver disease.

Seafood, seaweed and soy products were among the foods that helped slow the progression of liver fibrosis.

People who ate more fast food, as well as those with diabetes or obesity, had a higher risk for NAFLD.

Research confirms exercise as effective treatment for fatty liver disease.

BMI may not be the best way to assess health risks linked to excess weight.

Most outcomes were similar in lean and heavy people with fatty liver disease, but the lean group had higher liver-related mortality.

Some 20% of those with NAFLD also showed signs of liver fibrosis.

Among people with fatty liver disease, those with diabetes were more likely to advance by one fibrosis stage in less than six years.

Positive results announced by Madrigal Pharmaceuticals could potentially lead to the first drug approval for fatty liver disease.

Diabetes and a large waist circumference are predictors of liver fat accumulation and fibrosis.

People with a tendency to be active later in the day may be at greater risk for severe NAFLD.

Getting enough sleep provides improves your mood, helps maintain a healthy weight and may boost your immune system.

The Kansas Center for Metabolism and Obesity Research will research obesity-related diseases and train junior researchers.

The weight-to-height ratio, never meant as a diagnostic tool, is used to determine insurance coverage of weight loss therapies.

Second- and third-generation individuals in Los Angeles had a 35% and 61% higher risk, respectively, than those born in Mexico.

Higher daily alcohol consumption was linked to greater risk for MAFLD.